|
humans |
20 |
|
propofol |
19 |
|
diabetes |
16 |
|
dexmedetomidine |
14 |
|
female |
14 |
|
male |
14 |
|
anaesthesia |
13 |
|
pain |
12 |
|
analgesia |
11 |
|
myocardial ischemia injury |
11 |
|
remifentanil |
11 |
|
aged |
9 |
|
protein kinase cβ |
9 |
|
adiponectin |
8 |
|
aerosol |
8 |
|
antioxidants |
8 |
|
biology |
8 |
|
covid-19 |
8 |
|
jak2/stat3 |
8 |
|
oxidative stress |
8 |
|
pi3k/akt |
8 |
|
sevoflurane |
8 |
|
apoptosis |
7 |
|
enhanced recovery |
7 |
|
general anaesthesia |
7 |
|
intranasal |
7 |
|
opioid |
7 |
|
adult |
6 |
|
animals |
6 |
|
chronic pain |
6 |
|
diabetic cardiomyopathy |
6 |
|
ischemia reperfusion injury |
6 |
|
medical sciences |
6 |
|
middle aged |
6 |
|
perioperative |
6 |
|
supraglottic airway device |
6 |
|
surgery |
6 |
|
acetylcysteine - pharmacology - therapeutic use |
5 |
|
acute kidney injury |
5 |
|
adiponectin - biosynthesis - metabolism |
5 |
|
advanced ovarian cancer |
5 |
|
aerosol box |
5 |
|
allopurinol - pharmacology - therapeutic use |
5 |
|
anesthetics, inhalation - pharmacology |
5 |
|
anesthetics, intravenous - pharmacology |
5 |
|
antioxidants - pharmacology - therapeutic use |
5 |
|
complications |
5 |
|
cytoreduction |
5 |
|
dental |
5 |
|
dexmedetomidine - administration and dosage |
5 |
|
diabetes complications - drug therapy - metabolism - pathology - physiopathology |
5 |
|
diabetes mellitus |
5 |
|
disease models, animal |
5 |
|
education, medical, undergraduate |
5 |
|
general anesthesia |
5 |
|
glycogen synthase kinase |
5 |
|
heme oxygenase-1 |
5 |
|
hemodynamics - drug effects |
5 |
|
hong kong |
5 |
|
infarct size |
5 |
|
infection |
5 |
|
inflammation |
5 |
|
janus-activated kinase |
5 |
|
left ventricular hypertrophy |
5 |
|
manikin, intubation tent |
5 |
|
medical audit |
5 |
|
midazolam |
5 |
|
monitoring, intraoperative - methods |
5 |
|
myocardial hypertrophy and dysfunction |
5 |
|
neuropathic pain |
5 |
|
nrf2 |
5 |
|
oncology |
5 |
|
pain, postoperative - drug therapy |
5 |
|
rapid sequence intubation |
5 |
|
regional anaesthesia |
5 |
|
riot |
5 |
|
ruboxistaurin |
5 |
|
sedation |
5 |
|
signal transducer and activator of transcription 3 |
5 |
|
students, medical |
5 |
|
total intravenous anesthesia |
5 |
|
acute |
4 |
|
acute pain |
4 |
|
acute postoperative pain |
4 |
|
adolescent |
4 |
|
adult population |
4 |
|
aging |
4 |
|
anaesthesiology |
4 |
|
anesthesia, general |
4 |
|
audiovisual aids |
4 |
|
bispectral index (bis) |
4 |
|
blood loss, surgical - prevention & control |
4 |
|
blood pressure - drug effects |
4 |
|
blood transfusion |
4 |
|
brg1 |
4 |
|
cardiology - education |
4 |
|
cardioprotection |
4 |
|
cardiovascular diseases |
4 |
|
cardiovascular diseases - metabolism - physiopathology |
4 |
|
caveolin-3 |
4 |
|
colorectal surgery |
4 |
|
comprehension |
4 |
|
conscious sedation - methods |
4 |
|
dental surgery |
4 |
|
dose-response relationship, drug |
4 |
|
double-blind method |
4 |
|
fractured neck of femur |
4 |
|
guidelines |
4 |
|
hemostatics - therapeutic use |
4 |
|
hypnotics and sedatives |
4 |
|
intrathecal morphine |
4 |
|
intravenous: propofol |
4 |
|
ischaemia/reperfusion injury |
4 |
|
ischemic preconditioning |
4 |
|
isoflurane |
4 |
|
isoflurane postconditioning |
4 |
|
local |
4 |
|
molar, third - surgery |
4 |
|
morphine - administration & dosage |
4 |
|
myocardial ischaemia/reperfusion injury |
4 |
|
oxygen - metabolism |
4 |
|
paediatric |
4 |
|
pain - drug therapy |
4 |
|
pain, postoperative - diagnosis - prevention and control |
4 |
|
patient simulation |
4 |
|
pilot projects |
4 |
|
pkc-ε |
4 |
|
postoperative |
4 |
|
postoperative analgesia |
4 |
|
postoperative opioid consumption |
4 |
|
preoperative assessment |
4 |
|
prevalence |
4 |
|
propofol - pharmacology |
4 |
|
rat |
4 |
|
repeated non-invasive limb ischemic preconditioning |
4 |
|
respiratory infectious disease |
4 |
|
scoliosis - surgery |
4 |
|
shock - metabolism - physiopathology |
4 |
|
stat3 |
4 |
|
statins |
4 |
|
surveys and questionnaires |
4 |
|
teaching - methods |
4 |
|
tooth extraction - adverse effects |
4 |
|
total intravenous anaesthesia (tiva) |
4 |
|
young adult |
4 |
|
acute myocardial infarction |
3 |
|
adenosine |
3 |
|
administration, oral |
3 |
|
adrenergic alpha-2 receptor agonists - pharmacology |
3 |
|
allopurinol |
3 |
|
amp-activated protein kinase |
3 |
|
amygdala |
3 |
|
anaesthetics i.v., propofol |
3 |
|
anaesthetics volatile, sevoflurane |
3 |
|
analgesia - adverse effects |
3 |
|
analgesia intra-articular |
3 |
|
analgesic efficacy |
3 |
|
analgesics - therapeutic use |
3 |
|
analgesics non-opioid ketorolac |
3 |
|
analgesics, opioid - administration & dosage |
3 |
|
analgesics, opioid - administration and dosage |
3 |
|
analgesics, opioid - adverse effects |
3 |
|
analgesics, opioid - metabolism - therapeutic use |
3 |
|
analgesics, opioid - therapeutic use |
3 |
|
analysis of variance |
3 |
|
anesthesia |
3 |
|
anesthesia recovery period |
3 |
|
anesthesia, local |
3 |
|
anesthesia, obstetrical |
3 |
|
anesthesia, spinal |
3 |
|
anesthetics |
3 |
|
animal experiment |
3 |
|
antifibrinolytic agents - therapeutic use |
3 |
|
apoptosis - drug effects |
3 |
|
arginine - pharmacology |
3 |
|
asia |
3 |
|
auditing |
3 |
|
autophagy |
3 |
|
biological effects |
3 |
|
cardiac biomarkers |
3 |
|
cardiac complications |
3 |
|
cardiac protection |
3 |
|
cardiotonic agents |
3 |
|
cardiovascular agents - administration & dosage |
3 |
|
cesarean section |
3 |
|
child |
3 |
|
child, preschool |
3 |
|
children |
3 |
|
chloral hydrate |
3 |
|
chromatography, high pressure liquid |
3 |
|
cirrhosis |
3 |
|
clinical competence |
3 |
|
cognitive dysfunction |
3 |
|
contrast media |
3 |
|
controlled study |
3 |
|
coronary artery bypass graft surgery |
3 |
|
curriculum |
3 |
|
cyclooxygenase inhibitors - administration & dosage - blood - therapeutic use |
3 |
|
damage |
3 |
|
dexmedetomidine - administration and dosage - adverse effects - pharmacology |
3 |
|
difficult airway |
3 |
|
endovascular procedures |
3 |
|
enhanced recovery after surgery |
3 |
|
erythropoiesis |
3 |
|
erythropoietin |
3 |
|
evoked potentials, somatosensory - drug effects |
3 |
|
experimental mouse model |
3 |
|
femoral neck fracture |
3 |
|
forkhead box protein o1 |
3 |
|
formaldehyde |
3 |
|
fractured hip |
3 |
|
heart infarction size |
3 |
|
heart muscle ischemia |
3 |
|
heart rate - drug effects |
3 |
|
heart-type fatty acid binding protein |
3 |
|
hepatic ischaemiareperfusion injury |
3 |
|
hot temperature |
3 |
|
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use |
3 |
|
hyperalgesia |
3 |
|
hypotension - chemically induced |
3 |
|
hypotension - etiology |
3 |
|
hypothermia |
3 |
|
ibuprofen |
3 |
|
imaging |
3 |
|
infant |
3 |
|
infusions, intravenous |
3 |
|
infusions, parenteral |
3 |
|
injections, spinal |
3 |
|
ischaemia reperfusion injury |
3 |
|
ischemic postconditioning - methods |
3 |
|
ischemic preconditioning, myocardial |
3 |
|
ischemic preconditioning, myocardial - methods |
3 |
|
isoflurane - therapeutic use |
3 |
|
isoxazoles - administration & dosage - blood - therapeutic use |
3 |
|
ketorolac - administration & dosage - blood - therapeutic use |
3 |
|
l-arginine |
3 |
|
laparoscopy |
3 |
|
laryngeal mask airway |
3 |
|
liver |
3 |
|
liver - blood supply - drug effects - metabolism |
3 |
|
liver diseases - metabolism - prevention and control |
3 |
|
liver transplantation |
3 |
|
maxilla - surgery |
3 |
|
mice |
3 |
|
mice, inbred c57bl |
3 |
|
minimally invasive surgery |
3 |
|
mitochondria |
3 |
|
monitoring |
3 |
|
monitoring, somatosensory evoked potential |
3 |
|
morbidity |
3 |
|
morphine - administration and dosage |
3 |
|
morphine - administration and dosage - metabolism |
3 |
|
morphine - adverse effects |
3 |
|
mortality |
3 |
|
myocardial infarction - metabolism - pathology - prevention & control |
3 |
|
myocardial injury |
3 |
|
myocardial ischemia |
3 |
|
myocardial ischemia-reperfusion |
3 |
|
myocardial reperfusion injury |
3 |
|
myocardial reperfusion injury - metabolism - pathology - prevention & control |
3 |
|
myocardial reperfusion injury - prevention and control |
3 |
|
myocardium - pathology |
3 |
|
narcotic antagonists - pharmacology |
3 |
|
nausea - chemically induced |
3 |
|
neuroinflammation |
3 |
|
nf-κb |
3 |
|
nitrative stress |
3 |
|
nitric oxide synthase - drug effects - metabolism |
3 |
|
nitrosative stress |
3 |
|
nociceptors - drug effects |
3 |
|
non-cancer pain |
3 |
|
noncardiac surgery |
3 |
|
operative |
3 |
|
opioid rotation |
3 |
|
opioid therapy |
3 |
|
opioids |
3 |
|
osteotomy - adverse effects - methods |
3 |
|
outcome |
3 |
|
oxidative stress - drug effects |
3 |
|
pain clinics - standards |
3 |
|
pain management |
3 |
|
pain measurement |
3 |
|
parecoxib |
3 |
|
pathophysiological changes |
3 |
|
perioperative care |
3 |
|
perioperative management |
3 |
|
post-ischemic myocardial injury |
3 |
|
postconditioning |
3 |
|
postoperative care |
3 |
|
postoperative cognitive dysfunction |
3 |
|
postoperative complications |
3 |
|
postoperative complications - prevention & control |
3 |
|
postoperative pain |
3 |
|
preconditioning |
3 |
|
premedication - methods |
3 |
|
propofol - therapeutic use |
3 |
|
prospective studies |
3 |
|
protein kinases |
3 |
|
rats |
3 |
|
rats, sprague-dawley |
3 |
|
reaction time - drug effects |
3 |
|
receptors, opioid - agonists - metabolism |
3 |
|
receptors, opioid - drug effects - physiology |
3 |
|
receptors, opioid, delta - agonists |
3 |
|
receptors, opioid, kappa - agonists |
3 |
|
receptors, opioid, mu - agonists |
3 |
|
receptors, purinergic p1 - metabolism |
3 |
|
regional |
3 |
|
remote preconditioning |
3 |
|
reproducibility of results |
3 |
|
respiration disorders - chemically induced |
3 |
|
retrospective studies |
3 |
|
risk factors |
3 |
|
somatosensory cortex |
3 |
|
spinal opioid receptors |
3 |
|
statistics, nonparametric |
3 |
|
sulfonamides - administration & dosage - blood - therapeutic use |
3 |
|
surgery, spinal |
3 |
|
surgical injury |
3 |
|
surgical procedures, operative |
3 |
|
tau phosphorylation |
3 |
|
tau proteins |
3 |
|
time factors |
3 |
|
tolerance |
3 |
|
tomography |
3 |
|
tranexamic acid - therapeutic use |
3 |
|
treatment outcome |
3 |
|
trendelenburg |
3 |
|
tumor necrosis factor-a |
3 |
|
tumor necrosis factor-alpha - pharmacology |
3 |
|
valdecoxib |
3 |
|
vascular |
3 |
|
vascular diseases - surgery |
3 |
|
vascular remodeling |
3 |
|
vomiting - chemically induced |
3 |
|
15-f 2t-isoprostane |
2 |
|
acute kidney injury - chemically induced - physiopathology - prevention and control |
2 |
|
adjuvants pharmaceutical |
2 |
|
adjuvants, anesthesia |
2 |
|
adjuvants, pharmaceutic - therapeutic use |
2 |
|
administration |
2 |
|
administration, intranasal |
2 |
|
adrenergic beta-antagonists - therapeutic use |
2 |
|
affect - drug effects |
2 |
|
affective |
2 |
|
age distribution |
2 |
|
aged, 80 and over |
2 |
|
airborne |
2 |
|
airway management |
2 |
|
alcoholic cirrhosis |
2 |
|
alpha 2 agonists |
2 |
|
amides - administration and dosage |
2 |
|
amines - therapeutic use |
2 |
|
ampk |
2 |
|
anaesthesia induction |
2 |
|
anaesthetic |
2 |
|
anaesthetic conditioning |
2 |
|
anaesthetic techniques |
2 |
|
anaesthetics i.v. |
2 |
|
anaesthetics inhalational |
2 |
|
analgesia, patient-controlled - adverse effects |
2 |
|
analgesia, patient-controlled - methods |
2 |
|
analgesics |
2 |
|
analgesics non-opioid, gabapentin |
2 |
|
analgesics opioid, remifentanil |
2 |
|
analgesics, non-narcotic - therapeutic use |
2 |
|
analgesics, opioid - administration & dosage - adverse effects |
2 |
|
analgesics, opioid - administration and dosage - adverse effects |
2 |
|
analgesics, opioid - pharmacology |
2 |
|
anesthesia - methods |
2 |
|
anesthesia for middle ear surgery |
2 |
|
anesthesia induction |
2 |
|
anesthesia, dental - methods |
2 |
|
anesthesia, dental/methods |
2 |
|
anesthesia, intravenous |
2 |
|
anesthetic preconditioning |
2 |
|
anesthetics, local - administration and dosage |
2 |
|
aneurysm, false - etiology - radiography |
2 |
|
angiography, computerised tomography |
2 |
|
angioplasty, balloon, coronary - methods |
2 |
|
animal model |
2 |
|
ankylosing spondylitis |
2 |
|
anoxia - blood |
2 |
|
anterior cingulate cortex |
2 |
|
anti-anxiety agents - therapeutic use |
2 |
|
antidepressive agents - therapeutic use |
2 |
|
antioxidant |
2 |
|
antioxidants - therapeutic use |
2 |
|
aorta - ultrasonography |
2 |
|
aortic aneurysm, abdominal - surgery |
2 |
|
arterial puncture |
2 |
|
arthroplasty |
2 |
|
aspirin |
2 |
|
autoimmune disease |
2 |
|
awareness |
2 |
|
beta blockers |
2 |
|
bilirubin |
2 |
|
bleeding |
2 |
|
blood coagulation - drug effects |
2 |
|
blood coagulation tests |
2 |
|
blood loss |
2 |
|
blood pressure monitors |
2 |
|
bone cement implantation syndrome |
2 |
|
bone screws |
2 |
|
bosentan |
2 |
|
brachial plexus |
2 |
|
brahma-related gene 1 |
2 |
|
carcinoma, hepatocellular - therapy |
2 |
|
cardiac |
2 |
|
cardiac hypertrophy |
2 |
|
cardiac output |
2 |
|
cardiac preconditioning |
2 |
|
cardiac surgery |
2 |
|
cardiomyocytes |
2 |
|
cardiomyopathy |
2 |
|
cardiopulmonary bypass |
2 |
|
cardiotonic agents - pharmacology |
2 |
|
cardiovascular diseases - drug therapy - physiopathology - ultrasonography |
2 |
|
cardiovascular monitoring |
2 |
|
carotid artery, common |
2 |
|
catheterization, swan-ganz |
2 |
|
cell proliferation |
2 |
|
cell survival - drug effects |
2 |
|
cells, cultured |
2 |
|
central venous catheterization |
2 |
|
ceramides - biosynthesis |
2 |
|
cholecystectomy, laparoscopic |
2 |
|
chronic |
2 |
|
chronic disease |
2 |
|
chronic disease - drug therapy |
2 |
|
circumcision, male |
2 |
|
cirrhotic cardiomyopathy |
2 |
|
clinical competence - standards |
2 |
|
clinical protocols |
2 |
|
coagulation |
2 |
|
comorbidity |
2 |
|
complications, renal |
2 |
|
connexin |
2 |
|
conscious sedation |
2 |
|
conscious sedation/methods |
2 |
|
consensus |
2 |
|
contact |
2 |
|
contrast media - adverse effects |
2 |
|
controlled hypotension |
2 |
|
coronary vessels - physiology |
2 |
|
coronavirus |
2 |
|
cranial nerve diseases - drug therapy |
2 |
|
creatine kinase - metabolism |
2 |
|
curriculum - standards |
2 |
|
curriculum, standards |
2 |
|
cyclohexanecarboxylic acids - therapeutic use |
2 |
|
data collection |
2 |
|
deamino arginine vasopressin - therapeutic use |
2 |
|
delirium - prevention & control |
2 |
|
droplet |
2 |
|
drug administration schedule |
2 |
|
drug resistance - physiology |
2 |
|
ear, middle - surgery |
2 |
|
echocardiography |
2 |
|
echocardiography, transesophageal |
2 |
|
education, medical - methods |
2 |
|
education, medical, undergraduate - methods |
2 |
|
education, medical/methods |
2 |
|
effect-site |
2 |
|
electroencephalography - drug effects |
2 |
|
emergencies |
2 |
|
endoscopic retrograde cholangiopancreatography (ercp) |
2 |
|
endothelial cells - drug effects - physiology |
2 |
|
endothelial nitric oxide synthase |
2 |
|
endothelin-1 antagonist |
2 |
|
endovascular procedures - methods - trends |
2 |
|
environmental enrichment |
2 |
|
enzyme activation |
2 |
|
enzyme inhibitors - therapeutic use |
2 |
|
equipment |
2 |
|
equipment design |
2 |
|
esophagectomy |
2 |
|
fasting |
2 |
|
femoral neck fractures - surgery |
2 |
|
fluid replacement |
2 |
|
fluid therapy - methods |
2 |
|
fluids, i.v. |
2 |
|
focus |
2 |
|
focus groups - methods |
2 |
|
focus groups, methods |
2 |
|
foxo |
2 |
|
foxo1 |
2 |
|
free flap reconstruction |
2 |
|
free radical scavengers |
2 |
|
functional capacity |
2 |
|
functional laterality - physiology |
2 |
|
gamma-aminobutyric acid - therapeutic use |
2 |
|
gap junction |
2 |
|
gastrointestinal surgery |
2 |
|
gene expression regulation - drug effects - physiology |
2 |
|
geriatric anaesthesia |
2 |
|
glutathione peroxidase - metabolism |
2 |
|
guideline |
2 |
|
health surveys |
2 |
|
heart - drug effects - physiopathology |
2 |
|
heart, coronary occlusion |
2 |
|
heart, ischaemia |
2 |
|
hemoglobins - drug effects |
2 |
|
hepatectomy |
2 |
|
hepatopulmonary syndrome |
2 |
|
hepatorenal syndromes |
2 |
|
high-flow nasal oxygen |
2 |
|
hip |
2 |
|
hippocampus |
2 |
|
hippocampus - metabolism |
2 |
|
human |
2 |
|
human umbilical vein endothelial cells |
2 |
|
hydrogen peroxide - metabolism |
2 |
|
hyperalgesia - metabolism |
2 |
|
hypnotics and sedatives - administration & dosage - pharmacology |
2 |
|
hypnotics and sedatives - administration and dosage |
2 |
|
hypotension |
2 |
|
hypovolaemia |
2 |
|
hypoxaemia |
2 |
|
hypoxaemia perioperative |
2 |
|
hypoxia |
2 |
|
incidence |
2 |
|
inducible no synthase (inos) |
2 |
|
infusions, intravenous - adverse effects - statistics & numerical data |
2 |
|
intestinal mucosa - metabolism - pathology - ultrastructure |
2 |
|
intraoperative care |
2 |
|
intravenous |
2 |
|
intravenous anaesthesia |
2 |
|
intravenous anaesthetics |
2 |
|
intubation, intratracheal |
2 |
|
intubation, intratracheal - adverse effects |
2 |
|
intubation, tracheal, retropharyngeal abscess, pseudo-aneurysm |
2 |
|
ischaemia-reperfusion injury |
2 |
|
ischaemia/reperfusion |
2 |
|
ischaemic conditioning |
2 |
|
ischemia reperfusion |
2 |
|
ischemia/reperfusion injury |
2 |
|
ischemic heart disease |
2 |
|
ischemic post-conditioning |
2 |
|
isoflurane - pharmacology |
2 |
|
isoprostanes - pharmacology |
2 |
|
joint replacement |
2 |
|
kidney injury |
2 |
|
kidney, failure |
2 |
|
knee |
2 |
|
laparoscopy: cholecystectomy |
2 |
|
laryngeal mask |
2 |
|
laryngoscopes |
2 |
|
laryngoscopy |
2 |
|
learning |
2 |
|
liver cirrhosis - blood - surgery |
2 |
|
liver failure |
2 |
|
liver neoplasms - therapy |
2 |
|
malnutrition |
2 |
|
malondialdehyde - analysis |
2 |
|
manikin |
2 |
|
measurement techniques |
2 |
|
medical |
2 |
|
mental recall - drug effects |
2 |
|
metabolism |
2 |
|
methods |
2 |
|
microscopy, electron, transmission |
2 |
|
midazolam - administration & dosage - blood - pharmacology |
2 |
|
midazolam - administration & dosage - pharmacology |
2 |
|
monitoring, intraoperative |
2 |
|
monitoring, intraoperative - instrumentation |
2 |
|
morphine |
2 |
|
morphine - administration & dosage - adverse effects |
2 |
|
morphine - administration and dosage - adverse effects |
2 |
|
morphine - pharmacology |
2 |
|
motion artefact |
2 |
|
movement |
2 |
|
multimodal analgesia |
2 |
|
myocardial infarction - pathology |
2 |
|
myocardial infarction - pathology - prevention & control |
2 |
|
myocardial ischaemia/reperfusion |
2 |
|
myocardial protection |
2 |
|
myocardial reperfusion injury - drug therapy - pathology |
2 |
|
myocardial reperfusion injury - metabolism - physiopathology |
2 |
|
myocardial reperfusion injury - physiopathology - prevention and control |
2 |
|
myocardial reperfusion injury - prevention & control |
2 |
|
naloxone - analogs & derivatives - pharmacology |
2 |
|
network meta-analysis |
2 |
|
neuralgia - metabolism |
2 |
|
nf-kappa b - biosynthesis |
2 |
|
nf-kappa b - metabolism |
2 |
|
nitrous oxide |
2 |
|
nonmem |
2 |
|
nrk52e cells |
2 |
|
nuclear factor-erythroid-2-related factor-2 |
2 |
|
orthopaedic procedures |
2 |
|
osmolar concentration |
2 |
|
otologic surgical procedures - methods |
2 |
|
outcome assessment (health care) - methods |
2 |
|
oximeters |
2 |
|
oximetry |
2 |
|
oximetry - methods |
2 |
|
oxygen - blood |
2 |
|
oxygen consumption - physiology |
2 |
|
paediatric anaesthesia |
2 |
|
pain measurement - methods |
2 |
|
pain, chronic |
2 |
|
pain, postoperative - drug therapy - physiopathology - prevention & control |
2 |
|
pain, postoperative - epidemiology - etiology - pathology |
2 |
|
pain, postoperative - prevention & control |
2 |
|
pain: postoperative |
2 |
|
patient care team |
2 |
|
patient satisfaction |
2 |
|
patient-centred medical home care |
2 |
|
patient-controlled |
2 |
|
perioperative period |
2 |
|
peripheral nervous system diseases - complications - metabolism - pathology |
2 |
|
peroxynitrite |
2 |
|
pharmacodynamics |
2 |
|
pharmacokinetics |
2 |
|
pharynx - injuries |
2 |
|
phimosis - surgery |
2 |
|
photoplethysmography |
2 |
|
phthalimides - pharmacology |
2 |
|
physical phenomena |
2 |
|
physical therapy modalities |
2 |
|
physics |
2 |
|
piperidines - therapeutic use |
2 |
|
platelet count |
2 |
|
pleiotropic |
2 |
|
pneumoperitoeum |
2 |
|
pneumoperitoneum |
2 |
|
pneumothorax |
2 |
|
post-operative |
2 |
|
post-operative pain |
2 |
|
postoperative complication |
2 |
|
postoperative complications - chemically induced |
2 |
|
postoperative nausea and vomiting |
2 |
|
postoperative nausea and vomiting - chemically induced - epidemiology - prevention & control |
2 |
|
postoperative nausea and vomiting - prevention & control |
2 |
|
postoperative period |
2 |
|
posture - physiology |
2 |
|
potassium - blood |
2 |
|
pre-oxygenation |
2 |
|
pregnancy |
2 |
|
prehabilitation |
2 |
|
premedication, anxiolysis |
2 |
|
preoperative care |
2 |
|
prevention |
2 |
|
procedural sedation |
2 |
|
propanolamines - therapeutic use |
2 |
|
propofol - administration & dosage - blood - pharmacology |
2 |
|
propofol administration |
2 |
|
propofol: administration |
2 |
|
prostatic neoplasms - therapy |
2 |
|
protein kinase c - physiology |
2 |
|
protein kinase c β2 |
2 |
|
psychomotor performance - drug effects |
2 |
|
psychomotor recovery |
2 |
|
pterostilbene |
2 |
|
pulse - drug effects |
2 |
|
pulse - physiology |
2 |
|
quaternary ammonium compounds - pharmacology |
2 |
|
questionnaires |
2 |
|
questionnaires, hong kong |
2 |
|
rabbits |
2 |
|
randomized controlled trials as topic |
2 |
|
rap1 |
2 |
|
rapid sequence induction |
2 |
|
rats, wistar |
2 |
|
reactive oxygen species - metabolism |
2 |
|
receptors, opioid |
2 |
|
receptors, opioid - agonists |
2 |
|
receptors, opioid, delta - agonists - antagonists and inhibitors |
2 |
|
receptors, opioid, kappa - agonists - antagonists and inhibitors |
2 |
|
reconstructive surgery |
2 |
|
reflexes, laryngeal |
2 |
|
reperfusion injury - drug therapy - metabolism - pathology |
2 |
|
reperfusion injury - prevention & control |
2 |
|
respiratory insufficiency - chemically induced - epidemiology - prevention & control |
2 |
|
retropharyngeal abscess - etiology - radiography |
2 |
|
rna, messenger - analysis |
2 |
|
scoliosis surgery |
2 |
|
self administration - adverse effects - statistics & numerical data |
2 |
|
sensitivity and specificity |
2 |
|
shoulder |
2 |
|
signal transduction |
2 |
|
sodium - blood |
2 |
|
somatosensory cortex - metabolism |
2 |
|
somatosensory evoked potential |
2 |
|
sonophoresis |
2 |
|
sphingomyelin phosphodiesterase - genetics |
2 |
|
spinal |
2 |
|
spinal anaesthesia |
2 |
|
spinal cord - metabolism |
2 |
|
standards |
2 |
|
statin |
2 |
|
stattic |
2 |
|
students |
2 |
|
sulfonamides - pharmacology |
2 |
|
superoxide dismutase - metabolism |
2 |
|
surgical procedures, minimally invasive - methods |
2 |
|
systematic review |
2 |
|
target-controlled infusion |
2 |
|
tau |
2 |
|
techniques: patient controlled, pca |
2 |
|
telomere |
2 |
|
thalamus |
2 |
|
thermodilution |
2 |
|
thiopental - administration & dosage - blood - pharmacology |
2 |
|
thiopentone |
2 |
|
thrive |
2 |
|
thrombelastography® |
2 |
|
titration |
2 |
|
tomography, x-ray computed |
2 |
|
tooth extraction |
2 |
|
tourniquet |
2 |
|
transoesophageal echocardiography: acoustic quantification |
2 |
|
tumor necrosis factor β |
2 |
|
ultrasonic therapy - methods |
2 |
|
ultrasonography |
2 |
|
urology |
2 |
|
vascular endothelial cells |
2 |
|
vascular endothelial growth factor |
2 |
|
ventricular function, left |
2 |
|
volatile |
2 |
|
vomiting, nausea |
2 |
|
wakefulness - drug effects |
2 |
|
α2-agonists |
2 |
|
abdomen - surgery |
1 |
|
accidents, occupational |
1 |
|
acetaminophen - pharmacokinetics - therapeutic use |
1 |
|
acetaminophen - therapeutic use |
1 |
|
acupuncture |
1 |
|
acute disease |
1 |
|
administration, topical |
1 |
|
adrenergic alpha-agonists - administration and dosage |
1 |
|
air pollutants, occupational - standards - toxicity |
1 |
|
airway |
1 |
|
airway extubation |
1 |
|
airway obstruction - complications |
1 |
|
aldrete score |
1 |
|
alfentanil |
1 |
|
alfentanil - administration & dosage - adverse effects |
1 |
|
alfentanil - administration and dosage |
1 |
|
alfentanil - blood - therapeutic use |
1 |
|
alpha2-adrenergic receptor |
1 |
|
ambulatory surgical procedures |
1 |
|
american academy of pediatrics (aap) |
1 |
|
american society of anesthesiologists (asa) |
1 |
|
anaesthesia and analgesia |
1 |
|
anaesthesia complications |
1 |
|
anaesthesia intravenous |
1 |
|
anaesthesia research |
1 |
|
anaesthesia, depth |
1 |
|
anaesthesia, intravenous; propofol |
1 |
|
anaesthesia, local; conscious sedation, dental sedation |
1 |
|
anaesthesia, neurosurgical |
1 |
|
anaesthesia: moyamoya disease, neurosurgical, normocarbia |
1 |
|
anaesthesia: preoperative |
1 |
|
anaesthesia: spinal obstetric, caesarean section |
1 |
|
anaesthesia; obstetric |
1 |
|
anaesthetic techniques, laryngoscopy |
1 |
|
anaesthetic techniques, regional: brachial plexus |
1 |
|
anaesthetic techniques, regional; spinal |
1 |
|
anaesthetic techniques: infiltration, epidural, caudal |
1 |
|
anaesthetic training |
1 |
|
anaesthetics, intravenous: propofol |
1 |
|
anaesthetics, intravenous; propofol |
1 |
|
anaesthetics, local: bupivacaine |
1 |
|
anaesthetics: sevoflurane, propofol |
1 |
|
analgesia - methods |
1 |
|
analgesia, epidural - adverse effects |
1 |
|
analgesia, obstetrical - adverse effects |
1 |
|
analgesia, patient-controlled |
1 |
|
analgesia, patient-controlled - instrumentation |
1 |
|
analgesia: patient-controlled, target-controlled infusion |
1 |
|
analgesics, diclofenac pethidine |
1 |
|
analgesics, non-narcotic - administration & dosage |
1 |
|
analgesics, opioid - administration & dosage - therapeutic use |
1 |
|
analgesics, opioid - blood - therapeutic use |
1 |
|
analgesics: alfentanil |
1 |
|
androstanols - administration & dosage |
1 |
|
anemia, hypoplastic, congenital - complications - therapy |
1 |
|
anesthesia - adverse effects - methods |
1 |
|
anesthesia - methods - standards |
1 |
|
anesthesia department, hospital |
1 |
|
anesthesia, caudal |
1 |
|
anesthesia, conduction |
1 |
|
anesthesia, intravenous - adverse effects |
1 |
|
anesthesia, obstetrical - adverse effects |
1 |
|
anesthesia, spinal - adverse effects |
1 |
|
anesthesia,-intravenous |
1 |
|
anesthesiology - education |
1 |
|
anesthesiology - education - statistics & numerical data |
1 |
|
anesthesiology - standards - trends |
1 |
|
anesthesiology, education |
1 |
|
anesthesist |
1 |
|
anesthetics - administration and dosage - adverse effects |
1 |
|
anesthetics, combined - administration & dosage - adverse effects - therapeutic use |
1 |
|
anesthetics, inhalation |
1 |
|
anesthetics, inhalation - toxicity |
1 |
|
anesthetics, intravenous - administration & dosage |
1 |
|
anesthetics, intravenous - administration & dosage - adverse effects |
1 |
|
anesthetics, intravenous - administration and dosage |
1 |
|
anesthetics, intravenous - administration and dosage - blood |
1 |
|
anesthetics, intravenous - administration and dosage - blood - pharmacology |
1 |
|
anesthetics, intravenous - adverse effects |
1 |
|
anesthetics, local - administration & dosage - therapeutic use |
1 |
|
anesthetics, local - adverse effects |
1 |
|
antagonism |
1 |
|
anthropometry |
1 |
|
anti-inflammatory agents, non-steroidal - therapeutic use |
1 |
|
anti-inflammatory-agents,-non-steroidal-administration-and-dosage |
1 |
|
anticoagulation |
1 |
|
antiemetics - administration and dosage - therapeutic use |
1 |
|
antihypertensive drugs |
1 |
|
antipruritics - therapeutic use |
1 |
|
anxiety |
1 |
|
anxiety - prevention & control |
1 |
|
apgar score |
1 |
|
appointments and schedules |
1 |
|
aprepitant |
1 |
|
arm injuries - surgery |
1 |
|
arrhythmias |
1 |
|
arterial pressure |
1 |
|
arthroscopy |
1 |
|
asian continental ancestry group |
1 |
|
assessment |
1 |
|
atomizer |
1 |
|
atracurium - administration & dosage - analogs & derivatives |
1 |
|
atropine |
1 |
|
atropine - administration & dosage |
1 |
|
atropine - pharmacology |
1 |
|
attention - drug effects - physiology |
1 |
|
attitude |
1 |
|
autophagic flux |
1 |
|
basic life support (bls) |
1 |
|
behavior - drug effects |
1 |
|
benzodiazepines |
1 |
|
biological hazard |
1 |
|
bispectral index |
1 |
|
blood conservation |
1 |
|
blood patch, epidural |
1 |
|
blood pressure |
1 |
|
blood pressure - drug effects - physiology |
1 |
|
blood pressure determination - methods |
1 |
|
blood pressure monitoring |
1 |
|
blood pressure monitors - standards |
1 |
|
bone-and-bones-surgery |
1 |
|
brain: electroencephalography |
1 |
|
bronchial blocker |
1 |
|
bronchoscope |
1 |
|
bronchoscopes |
1 |
|
bronchoscopy |
1 |
|
bronchoscopy - history - methods |
1 |
|
bupivacaine |
1 |
|
burnout |
1 |
|
burnout, professional - epidemiology - psychology |
1 |
|
caffeine - pharmacology |
1 |
|
calcium - metabolism |
1 |
|
calcium signaling - drug effects |
1 |
|
calmodulin - antagonists and inhibitors - metabolism |
1 |
|
cancer |
1 |
|
carbon dioxide - blood |
1 |
|
carcinoma: oesophagus |
1 |
|
cardiac morbidity: pre‐operative factors |
1 |
|
cardiopulmonary resuscitation - psychology |
1 |
|
cardiotonic agents - administration and dosage - pharmacology |
1 |
|
cardiotonic agents - pharmacology - therapeutic use |
1 |
|
cardiovascular effect |
1 |
|
cardiovascular system |
1 |
|
career choice |
1 |
|
cataract surgery |
1 |
|
catheter |
1 |
|
centenarians |
1 |
|
central venous catheterisation |
1 |
|
central venous pressure - physiology |
1 |
|
cerebral hemorrhage - surgery |
1 |
|
cerebral ventricles - blood supply |
1 |
|
chelerythrine |
1 |
|
chemistry, pharmaceutical |
1 |
|
chi-square distribution |
1 |
|
child behavior - drug effects |
1 |
|
child, hospitalized |
1 |
|
china |
1 |
|
china - ethnology |
1 |
|
circumcision, male - adverse effects |
1 |
|
clinical practice |
1 |
|
clinical protocol |
1 |
|
clinical trials |
1 |
|
colorectal surgery - methods |
1 |
|
competencies |
1 |
|
complex regional pain syndrome |
1 |
|
complex regional pain syndromes - drug therapy - psychology - therapy |
1 |
|
complication |
1 |
|
complications, intubation endobronchial |
1 |
|
complications: cerebral ischaemia |
1 |
|
complications: duchenne's muscular dystrophy, cardiac arrest |
1 |
|
complications; hypotension |
1 |
|
congenital lung lesions |
1 |
|
conscious sedation - methods - psychology |
1 |
|
consciousness - drug effects |
1 |
|
consistency: time, training, practice |
1 |
|
coronary artery disease |
1 |
|
craniotomy |
1 |
|
credentialing |
1 |
|
cricothyroidotomy |
1 |
|
cross-over studies |
1 |
|
cyclooxygenase-inhibitors-administration-and-dosage |
1 |
|
cytosolic-calcium |
1 |
|
data interpretation, statistical |
1 |
|
decision making |
1 |
|
deep brain stimulation - adverse effects - contraindications - instrumentation |
1 |
|
deep learning |
1 |
|
deep vein thrombosis |
1 |
|
degenerative diseases of the spine |
1 |
|
dental sedation |
1 |
|
dexmedetomidine - administration & dosage |
1 |
|
diagnostic tests, routine - standards - utilization |
1 |
|
diazepam |
1 |
|
diclofenac-administration-and-dosage |
1 |
|
difficult laryngoscopy |
1 |
|
direct |
1 |
|
disease outbreaks |
1 |
|
diskectomy |
1 |
|
disposable equipment |
1 |
|
disposable equipment - standards |
1 |
|
doxorubicin |
1 |
|
drops |
1 |
|
drug monitoring - methods |
1 |
|
echocardiogram |
1 |
|
edema |
1 |
|
education, medical, graduate |
1 |
|
education, medical, graduate - statistics & numerical data |
1 |
|
educational measurement |
1 |
|
educational status |
1 |
|
elderly |
1 |
|
electric stimulation |
1 |
|
electrodes, implanted |
1 |
|
electroencephalography |
1 |
|
embolism, air - diagnosis - etiology |
1 |
|
embolism, air - etiology - ultrasonography |
1 |
|
emergence delirium |
1 |
|
endoscopy |
1 |
|
endotracheal extubation |
1 |
|
endotracheal intubation |
1 |
|
entrustable professional activity |
1 |
|
environmental pollution |
1 |
|
enzymes, lysosomal, n-acetyl-b-d-glucosaminidase |
1 |
|
ephedrine - therapeutic use |
1 |
|
equipment and supplies, hospital - standards |
1 |
|
equipment failure |
1 |
|
equipment, airway |
1 |
|
equipment, stimulators |
1 |
|
equipment, tubes tracheal |
1 |
|
equipment: t-y stent |
1 |
|
equipment; ovassapian airway, williams airway intubator, bronchoscope |
1 |
|
esophageal neoplasms - complications - surgery |
1 |
|
esophagus |
1 |
|
ethics |
1 |
|
evaluation studies as topic |
1 |
|
evoked potentials, auditory - drug effects - physiology |
1 |
|
extubation |
1 |
|
facial analysis |
1 |
|
family - psychology |
1 |
|
femoral neck fractures |
1 |
|
fentanyl - administration & dosage |
1 |
|
fentanyl - therapeutic use |
1 |
|
fetal blood - analysis |
1 |
|
fiber optic technology - instrumentation |
1 |
|
fiberoptic bronchoscopy |
1 |
|
finapres 2300e |
1 |
|
fingers |
1 |
|
fingers - physiology |
1 |
|
flexible bronchoscopy |
1 |
|
fracture fixation, internal - adverse effects |
1 |
|
frailty |
1 |
|
geriatric |
1 |
|
geriatrics |
1 |
|
gf109203x |
1 |
|
glottis |
1 |
|
grants |
1 |
|
greenhouse effect |
1 |
|
gsk3β |
1 |
|
guideline adherence |
1 |
|
haemodynamics |
1 |
|
headache - etiology - therapy |
1 |
|
health care surveys - statistics & numerical data |
1 |
|
health personnel |
1 |
|
health personnel - psychology - statistics & numerical data |
1 |
|
health plan implementation |
1 |
|
health status |
1 |
|
heart |
1 |
|
heart arrest - etiology |
1 |
|
heart failure |
1 |
|
hematologic tests - instrumentation |
1 |
|
hematological parameters |
1 |
|
hemoglobins - analysis |
1 |
|
hepatology |
1 |
|
hereditary sensory and motor neuropathy - complications |
1 |
|
hip fractures |
1 |
|
history, 19th century |
1 |
|
history, 20th century |
1 |
|
hong kong - epidemiology |
1 |
|
hospitals, teaching - statistics and numerical data |
1 |
|
humidity |
1 |
|
hypertension |
1 |
|
hypnotics and sedatives - administration & dosage |
1 |
|
hypotension - etiology - prevention & control |
1 |
|
iatrogenic disease |
1 |
|
infant, newborn - physiology |
1 |
|
infectious disease transmission, patient-to-professional |
1 |
|
infectious disease transmission, patient-to-professional - prevention and control |
1 |
|
inflammatory mediators |
1 |
|
infusion |
1 |
|
injections, intravenous |
1 |
|
injections, intravenous - adverse effects |
1 |
|
intensive care |
1 |
|
intestine |
1 |
|
intra-tracheal |
1 |
|
intracerebroventricular |
1 |
|
intranasal dexmedetomidine |
1 |
|
intranasal midazolam |
1 |
|
intraoperative care - methods |
1 |
|
intraoperative complications |
1 |
|
intraoperative complications - diagnosis |
1 |
|
intraoperative complications - etiology - ultrasonography |
1 |
|
intraoperative period |
1 |
|
intravenous anaesthetics, propofol |
1 |
|
intravenous: propofol, target-controlled infusion |
1 |
|
intubating laryngeal mask |
1 |
|
intubation |
1 |
|
intubation, intratracheal - history - methods |
1 |
|
intubation, intratracheal - instrumentation |
1 |
|
intubation, intratracheal - methods |
1 |
|
intubation, intratracheal - standards |
1 |
|
intubation, intratracheal/methods |
1 |
|
intubation, tracheal, position |
1 |
|
intubation, tracheal; fibreoptic |
1 |
|
investigations |
1 |
|
irritable mood - drug effects |
1 |
|
ischemia |
1 |
|
ischemia - etiology |
1 |
|
ischemia-reperfusion injury |
1 |
|
ischemic attack, transient - surgery |
1 |
|
isoflurane - administration and dosage - adverse effects |
1 |
|
isotonic solutions |
1 |
|
jaundice, obstructive - complications - physiopathology |
1 |
|
job satisfaction |
1 |
|
joint commission international |
1 |
|
ketamine |
1 |
|
ketamine - therapeutic use |
1 |
|
ketoacidosis |
1 |
|
kidney, function, nephrotoxicity |
1 |
|
kidney-drug-effects |
1 |
|
knowledge, attitudes, practice |
1 |
|
laryngoscopes - history |
1 |
|
laryngoscopy - history - methods |
1 |
|
laryngoscopy - methods |
1 |
|
lidocaine - administration & dosage - adverse effects - therapeutic use |
1 |
|
lithotripsy |
1 |
|
liver diseases - enzymology - etiology |
1 |
|
liver regeneration |
1 |
|
local anaesthesia |
1 |
|
local anesthesia |
1 |
|
local anesthetics |
1 |
|
lordosis - radiography |
1 |
|
lumbar vertebrae - surgery |
1 |
|
lumbosacral region - surgery |
1 |
|
lung, trachea |
1 |
|
magnetic resonance imaging - methods |
1 |
|
measurement |
1 |
|
measurement techniques, fibreoptic |
1 |
|
mechanical ventilation |
1 |
|
mechanisms: priming |
1 |
|
median neuropathy - surgery |
1 |
|
medical education |
1 |
|
medical-audit |
1 |
|
meperidine |
1 |
|
micro-circulation |
1 |
|
midazolam - administration & dosage - blood - pharmacokinetics - pharmacology |
1 |
|
mitogen-activated protein kinases |
1 |
|
mobile applications |
1 |
|
monitoring, bispectral index |
1 |
|
monitoring, electroencephalography |
1 |
|
monitoring, evoked potentials |
1 |
|
morale |
1 |
|
morphine - administration and dosage - pharmacology |
1 |
|
morphine - therapeutic use |
1 |
|
morphine preconditioning |
1 |
|
morpholines - administration and dosage - therapeutic use |
1 |
|
mouse |
1 |
|
mouth floor - ultrasonography |
1 |
|
movement - physiology |
1 |
|
moyamoya disease - physiopathology - surgery |
1 |
|
muscle relaxation - drug effects |
1 |
|
muscular dystrophies - complications |
1 |
|
myocardial infarction |
1 |
|
myocardial infarction - pathology - physiopathology |
1 |
|
myocardial ischemia - prevention and control |
1 |
|
myocardial ischemia preconditioning |
1 |
|
myocardial reperfusion |
1 |
|
myoclonus - chemically induced |
1 |
|
myocytes, cardiac - drug effects - metabolism |
1 |
|
neck of femur |
1 |
|
nephrectomy |
1 |
|
nerve block |
1 |
|
nerve block - adverse effects |
1 |
|
nerve injury |
1 |
|
neuraxial block |
1 |
|
neuroma - surgery |
1 |
|
neuroma, acoustic - surgery |
1 |
|
neuromuscular blockade |
1 |
|
neuromuscular blocking agents - administration & dosage |
1 |
|
neuromuscular blocking agents: cisatracurium, rocuronium |
1 |
|
neuromuscular disease: hereditary motor and sensory neuropathies |
1 |
|
neuromuscular nondepolarizing agents - administration & dosage |
1 |
|
neurophysiological monitoring |
1 |
|
neurosurgical procedures - methods |
1 |
|
neurosurgical procedures, craniotomy, supratentorial, posterior fossa, extracranial, intracranial vascular, transphenoidal hypophysectomy |
1 |
|
neurosurgical-procedures |
1 |
|
nifedipine - therapeutic use |
1 |
|
nitrous oxide - administration & dosage |
1 |
|
nitrous oxide - administration and dosage |
1 |
|
nitrous oxide - therapeutic use |
1 |
|
nonagenarians |
1 |
|
nonsteroidal anti-inflammatory drugs: celecoxib |
1 |
|
novel antihypertensives |
1 |
|
npo guidelines |
1 |
|
observer variation |
1 |
|
obstruction: trachea |
1 |
|
occupations |
1 |
|
odds ratio |
1 |
|
older patients |
1 |
|
ondansetron |
1 |
|
ondansetron - therapeutic use |
1 |
|
one‐lung ventilation |
1 |
|
operating rooms |
1 |
|
opioid receptor |
1 |
|
optimization |
1 |
|
oral surgical procedures |
1 |
|
oral surgical procedures - methods |
1 |
|
orthopaedic surgery |
1 |
|
oxidant stress |
1 |
|
oxygen - administration & dosage - blood |
1 |
|
ozone - chemistry |
1 |
|
pain - chemically induced - epidemiology |
1 |
|
pain - prevention & control |
1 |
|
pain measurement - drug effects |
1 |
|
pain measurement - statistics & numerical data |
1 |
|
pain, postoperative - physiopathology - prevention and control |
1 |
|
pain/etiology - physiopathology - therapy |
1 |
|
parents - psychology |
1 |
|
parkinsonism |
1 |
|
pathophysiology |
1 |
|
patient controlled analgesia system |
1 |
|
patient discharge |
1 |
|
patient education |
1 |
|
patient maintained sedation |
1 |
|
patient positioning |
1 |
|
patient selection |
1 |
|
patient-controlled analgesia |
1 |
|
patient-controlled, target-controlled infusion. analgesics, morphine, alfentanil |
1 |
|
pediatric anesthesia association |
1 |
|
pediatric sedation |
1 |
|
pediatrics |
1 |
|
pelvis - injuries - surgery |
1 |
|
penis |
1 |
|
penis - innervation |
1 |
|
percutaneous nephrolithotomy |
1 |
|
peri-operative |
1 |
|
perioperative visual loss |
1 |
|
peripheral nerve block |
1 |
|
peripheral nervous system neoplasms - surgery |
1 |
|
peri‐operative |
1 |
|
personal protection equipment |
1 |
|
personnel, hospital |
1 |
|
pethidine |
1 |
|
pharmacokinetics, propofol |
1 |
|
pharmacotherapy |
1 |
|
physical status: asa classification |
1 |
|
physician-patient relations |
1 |
|
physiotherapy |
1 |
|
piperidines - administration & dosage - therapeutic use |
1 |
|
piperidines - pharmacology |
1 |
|
piperidines - pharmacology - therapeutic use |
1 |
|
piperidines-pharmacology |
1 |
|
plasma substitutes - therapeutic use |
1 |
|
platelet transfusion |
1 |
|
pleural disease |
1 |
|
pneumothorax - etiology - radiography |
1 |
|
ponv |
1 |
|
position statement |
1 |
|
positive pressure ventilation |
1 |
|
post-tourniquet syndrome |
1 |
|
postoperative complications: pruritus |
1 |
|
postoperative nausea and vomiting - prevention and control |
1 |
|
postoperative pulmonary complications |
1 |
|
postoperative-complications-chemically-induced |
1 |
|
postoperative. analgesia |
1 |
|
posture |
1 |
|
practical |
1 |
|
pre-eclampsia - complications - drug therapy |
1 |
|
pre-operative factors |
1 |
|
preanesthetic medication |
1 |
|
pregnancy complications, hematologic - therapy |
1 |
|
pregnancy outcome |
1 |
|
premedication |
1 |
|
preoperative |
1 |
|
preoperative blood pressure |
1 |
|
prilocaine - administration & dosage - adverse effects - therapeutic use |
1 |
|
privileging |
1 |
|
programme evaluation |
1 |
|
prone position |
1 |
|
prone position: complications, hypotension, ischaemic hepatitis |
1 |
|
propofol - administration & dosage - adverse effects |
1 |
|
propofol - administration & dosage - pharmacology |
1 |
|
propofol - administration and dosage |
1 |
|
propofol - administration and dosage - blood |
1 |
|
propofol - administration and dosage - blood - pharmacology |
1 |
|
propofol - adverse effects |
1 |
|
prosthesis implantation - methods |
1 |
|
protective clothing |
1 |
|
protein kinase c |
1 |
|
protein kinase c - antagonists and inhibitors |
1 |
|
pruritus - chemically induced - prevention and control |
1 |
|
psychomotor assessment |
1 |
|
publishing |
1 |
|
pubmed |
1 |
|
pulmonary artery - physiology |
1 |
|
pulmonary aspiration |
1 |
|
pulse oximetry |
1 |
|
quality and patient safety |
1 |
|
raynaud disease - drug therapy - therapy |
1 |
|
receptors, opioid - antagonists and inhibitors - metabolism |
1 |
|
receptors, opioid, delta - antagonists and inhibitors - physiology |
1 |
|
receptors, opioid, kappa - antagonists and inhibitors - physiology |
1 |
|
reflex sympathetic dystrophy |
1 |
|
rehydration solutions - therapeutic use |
1 |
|
remifentanil preconditioning |
1 |
|
reperfusion |
1 |
|
research |
1 |
|
respiration |
1 |
|
respiration - drug effects |
1 |
|
respiratory distress syndrome, adult - etiology |
1 |
|
respiratory mechanics - drug effects - physiology |
1 |
|
respiratory paralysis - chemically induced - physiopathology |
1 |
|
respiratory system - anatomy and histology |
1 |
|
restraint |
1 |
|
review |
1 |
|
risk factors: perioperative |
1 |
|
robotic assisted laparoscopic prostatectomy |
1 |
|
ropivacaine |
1 |
|
safety |
1 |
|
scoliosis - complications - surgery |
1 |
|
scoliosis - etiology - surgery |
1 |
|
scoliosis: anaesthesia, surgery |
1 |
|
screening |
1 |
|
sedation; patient maintained, target-controlled infusion |
1 |
|
self administration |
1 |
|
self administration - psychology |
1 |
|
serotonin (5-hydroxy-tryptamine) |
1 |
|
severe acute respiratory syndrome - psychology |
1 |
|
sex characteristics |
1 |
|
sglt2 inhibitor |
1 |
|
signal pathways |
1 |
|
small children |
1 |
|
smartphone app |
1 |
|
sniffing position |
1 |
|
software design |
1 |
|
spinal puncture - adverse effects |
1 |
|
spine - surgery |
1 |
|
stents |
1 |
|
stress |
1 |
|
stress, psychological - epidemiology - psychology |
1 |
|
students, medical - psychology |
1 |
|
subarachnoid hemorrhage - surgery |
1 |
|
sufentanil |
1 |
|
sulfonamides - therapeutic use |
1 |
|
surgery department, hospital - statistics and numerical data |
1 |
|
surgery, neurological |
1 |
|
surgery: circumcision |
1 |
|
surgery: urology, extacorporeal shock wave lithotripsy |
1 |
|
surgery; oral |
1 |
|
surgical procedures, elective |
1 |
|
surgical procedures, elective - standards - utilization |
1 |
|
surgical procedures, elective - statistics and numerical data |
1 |
|
surgical risk |
1 |
|
sympathetic nervous system; pharmacology, ephedrine |
1 |
|
the childrens hospital of chongqing medical university |
1 |
|
the guangzhou women and childrens hospital |
1 |
|
thiopental - administration & dosage |
1 |
|
three axes alignment theory |
1 |
|
tinnitus - etiology |
1 |
|
tools |
1 |
|
total i.v. anaesthesia |
1 |
|
total intravenous anaesthesia |
1 |
|
tourniquet pain |
1 |
|
toxicity, renal |
1 |
|
trachea - anatomy & histology |
1 |
|
tracheal extubation |
1 |
|
tracheal intubation |
1 |
|
tracheal stenosis - etiology - surgery |
1 |
|
tracheostomy |
1 |
|
tramadol - therapeutic use |
1 |
|
transurethral resection of prostate |
1 |
|
transurethral resection of prostate syndrome |
1 |
|
ultrasonography, interventional - methods |
1 |
|
ultrasound guidance |
1 |
|
univers ity of michigan sedation scale (umss) |
1 |
|
uterus - blood supply |
1 |
|
valvular disease |
1 |
|
vasoconstrictor agents - therapeutic use |
1 |
|
vasodilator agents - therapeutic use |
1 |
|
ventilation: diaphragm |
1 |
|
ventricular myocyte |
1 |
|
victoria - epidemiology |
1 |
|
videolaryngoscopy |
1 |
|
volatile anaesthesia |
1 |
